Istradefylline
Brand name: Nourianz
Rank #442 of 500 drugs by total cost
$17.8M
Total Cost
7,061
Total Claims
$17.8M
Total Cost
248
Prescribers
$2,523
Cost per Claim
526
Beneficiaries
9,573
30-Day Fills
$72K
Avg Cost/Provider
28
Avg Claims/Provider
About Istradefylline
Istradefylline (sold as Nourianz) was prescribed 7,061 times by 248 Medicare Part D providers in 2023, costing the program $17.8M. At $2,523 per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 439 | Posaconazole (Posaconazole) | $18.0M | 7,163 |
| 440 | Metronidazole (Metronidazole) | $18.0M | 405,967 |
| 441 | Rufinamide (Rufinamide) | $18.0M | 8,793 |
| 442 | Istradefylline (Nourianz) | $17.8M | 7,061 |
| 443 | Encorafenib (Braftovi) | $17.6M | 1,209 |
| 444 | Cladribine (Mavenclad) | $17.5M | 228 |
| 445 | Enalapril Maleate (Enalapril Maleate) | $17.5M | 673,317 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology